RecruitingNot ApplicableNCT06978361
Comparison of Efficacy of Microneedling With Platelet Rich Plasma Vs Microneedling With Topical Insulin in the Treatment of Acne Scars
Comparison of Efficacy of Microneedling With Autologous Platelet-Rich Plasma vs Microneedling With Topical Insulin in the Treatment of Atrophic Acne Scars
Sponsor
Khyber Teaching Hospital
Enrollment
116 participants
Start Date
Mar 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
This study compares the outcome of two procedures for the treatment of atrophic acne scars.
Eligibility
Min Age: 18 YearsMax Age: 50 Years
Inclusion Criteria2
- Patients confirmed with post-acne atrophic scars . No prior treatment for scars in last 6 months.
- \-
Exclusion Criteria1
- Patient with active acne or other skin conditions (e.g eczema , psoriasis). Patients on oral or topical retinoids. Pregnant or lactating Mothers. Patients with recurrent herpes simplex infection. Previous Hx of keloids / hypertrophic scarring. Deranged blood glucose levels. Bleeding disorders
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREMicroneedling with autologous Platelet Rich Plasma
Patients in group A will undergo Microneedling with autologous PRP
PROCEDUREMicroneedling with topical insulin
Patients in group B will undergo Microneedling with Topical insulin ( regular).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06978361